ClinicalTrials.Veeva

Menu

COVID-19 and the Developement of Phobic Fears of Disease

M

Medical University of Graz

Status

Enrolling

Conditions

COVID19

Treatments

Other: Questionnaires for specific phobia

Study type

Observational

Funder types

Other

Identifiers

NCT04359121
32-354 ex 19/20

Details and patient eligibility

About

A lot of people suffer from phobias. Phobias concerning certain diseases are not rare. This study will examine whether the COVID-19 (Coronavirus Disease) crisis was able to rise phobias in people and if those with preexisting phobias or fears were more likely to develop a phobia concerning COVID. It will look at different subtypes - physicians, medical staff, general public (not medically affiliated) and patients with psychiatric disorders.

Enrollment

600 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Person gives written consent
  • Persons between 18-90 years of age (men and women)
  • No positive COVID infection known at time of first examination

Exclusion criteria

  • Dementia, Delirium (not able to give consent)
  • Not fulfilling the inclusion criteria
  • COVID infection known at first examination point

Trial design

600 participants in 4 patient groups

Physicians
Description:
Questionnaires
Treatment:
Other: Questionnaires for specific phobia
Medical staff
Description:
Questionnaires
Treatment:
Other: Questionnaires for specific phobia
General public
Description:
Questionnaires
Treatment:
Other: Questionnaires for specific phobia
Patients with psychiatric disorders
Description:
Questionnaires
Treatment:
Other: Questionnaires for specific phobia

Trial contacts and locations

1

Loading...

Central trial contact

Andreas Baranyi, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems